haya therapeutics
HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.
haya therapeutics has raised €58M across 2 funding rounds from 12 investors, most recently a Series A round in May 2025. Based in Lausanne, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€58M
€57,629,590
Funding rounds
2
Investors
12
distinct backers
Active since
2019-10
latest 2025-05
Funding by year
EUR raised per yearhaya therapeutics — funding by year — interactive chart.
Data table
| haya therapeutics — funding by year | |
|---|---|
| 2019 | €92k |
| 2025 | €58M |
Signals
High confidenceRaise-next likelihood71
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 7y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-08 | Series A | €58M | +ND Capital,4see Ventures,Alexandria Venture Investments,Apollo Health Ventures,Athos Capital,Bernina BioInvest+6 more | View deal → |
| 2019-10-01 | Other | €92k | — | View deal → |
Investors
12Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData